| Lauren Regueyra, MD | |
|
2150 W Central Ave Ste D, Toledo, OH 43606-3859 | |
| (419) 291-2192 | |
| (419) 479-3297 |
| Full Name | Lauren Regueyra |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 2150 W Central Ave Ste D, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679984371 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Toledo Hospital | 2961309638 | 75 |
News Archive
A five-year study by an international team led from the University of Leicester has found a way of ‘reversing' symptoms of neurodegenerative diseases such as Parkinson's and Alzheimer's – using fruit flies as test subjects.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.
Mobile phones using text messaging and monitoring have been shown to be useful additions to health programs. The objective of this study was to develop and evaluate a weight-loss intervention delivered by a smartphone app that supported individuals embarking on a diet and that was evidenced-based.
› Verified 6 days ago
| Entity Name | The Toledo Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407854771 PECOS PAC ID: 2961309638 Enrollment ID: O20031218001042 |
News Archive
A five-year study by an international team led from the University of Leicester has found a way of ‘reversing' symptoms of neurodegenerative diseases such as Parkinson's and Alzheimer's – using fruit flies as test subjects.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.
Mobile phones using text messaging and monitoring have been shown to be useful additions to health programs. The objective of this study was to develop and evaluate a weight-loss intervention delivered by a smartphone app that supported individuals embarking on a diet and that was evidenced-based.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Regueyra, MD 100 Madison Ave, Toledo, OH 43604-1516 Ph: () - | Lauren Regueyra, MD 2150 W Central Ave Ste D, Toledo, OH 43606-3859 Ph: (419) 291-2192 |
News Archive
A five-year study by an international team led from the University of Leicester has found a way of ‘reversing' symptoms of neurodegenerative diseases such as Parkinson's and Alzheimer's – using fruit flies as test subjects.
Cancer is a highly varied disease, with genetic differences among different tumor types, individuals and ancestral populations. These genetic differences can impact disease aggressiveness, the type of disease, and the response to therapy.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.
Mobile phones using text messaging and monitoring have been shown to be useful additions to health programs. The objective of this study was to develop and evaluate a weight-loss intervention delivered by a smartphone app that supported individuals embarking on a diet and that was evidenced-based.
› Verified 6 days ago
Nadine C Kassis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3425 Executive Pkwy, Suite 108, Toledo, OH 43606 Phone: 419-214-3192 | |
Anthony J. Armstrong, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4126 N Holland Sylvania Rd, Suite 220, Toledo, OH 43623 Phone: 419-517-7600 Fax: 419-517-7598 | |
Luigi O D'amato, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3740 W Sylvania Ave, Suite 103, Toledo, OH 43623 Phone: 419-473-6622 Fax: 419-473-6627 | |
Lance A Talmage, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2200 Fax: 419-479-3297 | |
Dr. Sonyoung Seo-patel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2192 Fax: 419-479-3297 | |
Dr. Kathryn Shannon Maloy, M.D., MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2213 Cherry St, Toledo, OH 43608 Phone: 419-251-3232 Fax: 419-251-3997 | |
Tiberiu S. Avram, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3020 N Mccord Rd Ste 201a, Toledo, OH 43615 Phone: 419-517-7727 Fax: 419-517-5036 |